Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|NEO212||NEO212 is a conjugate of temozolomide and perillyl alcohol, which may result in decreased cell migration and invasion, inhibition of Fak/Src signaling, and cytotoxicity (PMID: 29440289, PMID: 31839810).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Unknown unknown||malignant glioma||not applicable||NEO212||Preclinical||Actionable||In a preclinical study, treatment with NEO212 resulted in decreased cell migration and invasion, thereby slowing tumor progression in a glioma mouse model (PMID: 29440289).||29440289|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status|